Increased incidence of necrotizing enterocolitis associated with routine administration of Infloran™ in extremely preterm infants

Beneficial Microbes

Volumn 9, Issue 5, 2018, Pages 683-690

  Escribano, E ^a   Zozaya, C ^a   Madero, R ^a,b   Sanchez L ^a   Van Goudoever, J ^c   Rodriguez J M ^d,e   Saenz De Pipaon M ^a,b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Extremely low gestational age; Necrotizing enterocolitis; Probiotics; Sepsis

Indexed keywords

CORTICOSTEROID; INFLORAN; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; BREAST MILK; CLINICAL EVALUATION; CLINICAL OUTCOME; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFICACY; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; INFECTION RATE; LATE ONSET DISORDER; MAJOR CLINICAL STUDY; MORTALITY RATE; NECROTIZING ENTEROCOLITIS; PREMATURITY; PRENATAL PERIOD; PROSPECTIVE STUDY; SEPSIS; STAPHYLOCOCCAL BACTEREMIA; TREND STUDY; VERY LOW BIRTH WEIGHT; ADULT; CHEMISTRY; FEMALE; MALE; MICROBIOLOGY; NEWBORN; NEWBORN DISEASE; PREGNANCY; RETROSPECTIVE STUDY;

ADULT; ENTEROCOLITIS, NECROTIZING; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; PREGNANCY; PROBIOTICS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEPSIS;

EID: 85053622040     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2017.0098     Document Type: Article

References (17)

1. Al Faleh, K. and Anabrees, J., 2014. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 4: 005496.
2. AlFaleh, K. and Bassler, D., 2008. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 1: 005496.
3. Ament, S.M., De Groot, J.J., Maessen, J.M., Dirksen, C.D., Van der Weijden, T. and Kleijnen, J., 2015. Sustainability of professionals' adherence to clinical practice guidelines in medical care: A systematic review. BMJ Open 5: 008073.
4. Arboleya, S., Gonzalez, S., Salazar, N., Ruas-Madiedo, P., Clara, G., De los Reyes-Gavilán, C. and Gueimonde, M., 2012. Development of probiotic products for nutritional requirements of specific human populations. Engineering in Life Sciences 12: 368-376.
5. Bell, M.J., Ternberg, J.L., Feigin, R.D., Keating, J.P., Marshall, R., Barton, L. and Brotherton, T., 1978. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 187: 1-7.
6. Bermudez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., Gómez- Llorente, C. and Gil, A., 2012. Probiotic mechanisms of action. Annals of Nutrition and Metabolism 61: 160-174.
7. Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M. and Hammerman, C., 2005. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. Journal of Pediatrics 147: 192-196.
8. Boyle, R.J., Robins-Browne, R.M. and Tang, M.L., 2006. Probiotic use in clinical practice: What are the risks? American Journal of Clinical Nutrition 83: 1256-1264.
9. Cilieborg, M.S., Thymann, T., Siggers, R., Boye, M., Bering, S.B., Jensen, B.B. and Sangild, P.T., 2011. The incidence of necrotizing enterocolitis is increased following probiotic administration to preterm pigs. Journal of Nutrition 141: 223-230.
10. Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., Millar, M.R. and Probiotics in Preterm Infants Study Collaborative Group, 2016. Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial. Lancet 387: 649-660.
11. Deshpande, G., Rao, S., Patole, S. and Bulsara, M., 2010. Updated meta-Analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125: 921-930.
12. Grishin, A., Papillon, S., Bell, B., Wang, J. and Ford, H.R., 2013.The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Seminars in Pediatric Surgery 22: 69-75.
13. Hempel, S., Newberry, S., Ruelaz, A., Wang, Z., Miles, J.N., Suttorp, M.J., Johnsen, B., Shanman, R., Slusser, W., Fu, N., Smith, A., Roth, B., Polak, J., Motala, A., Perry, T. and Shekelle, P.G., 2011. Safety of probiotics used to reduce risk and prevent or treat disease. Evidence Report/Technology Assessment 200: 1-645.
14. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11: 506-514.
15. Hirvonen, J.J., Von Lode, P., Nevalainen, M., Rantakokko-Jalava, K., Kaukoranta, S.S., 2012. One-step sample preparation of positive blood cultures for the direct detection of methicillin-sensitive and -resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci within one hour using the automated GenomEra CDX™ PCR system. European Journal of Clinical Microbiology and Infectious Diseases 31: 2835-2842.
16. Hoyos, A.B., 1999. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. International Journal of Infectious Diseases 3: 197-202.
17. Kane, A.F., Bhatia, A.D., Denning, P.W., Shane, A.L. and Patel, R.M., 2018. Routine supplementation of Lactobacillus rhamnosus GG and risk of necrotizing enterocolitis in very low birth weight infants. Journal of Pediatrics 195: 73-79.